Komori
Changes in Officers3349COSMOS Pharmaceutical CorporationRetail

Notice Regarding Changes in Officers

After the annual general meeting of shareholders scheduled for 28 August 2026, the directors are scheduled to change, with Takemori Motoi (竹森 基) and Uno Fumiyasu (宇野 史泰) joining the Board of Directors, and Shibata Futoshi (柴田 太) changing from Director and General Manager of the Legal Affairs Department to General Manager of the Legal Affairs Department. Yokoyama Hideaki (横山 英昭) will continue as Representative Director and President.

Worth reading
33Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Who is moving to which position

Resolved 3 August 2026

Incoming appointee

2 items
Scheduled Appointment Date28 August 2026 (after being elected as directors at the annual general meeting of shareholders, their positions are scheduled to be formally determined at a Board of Directors meeting to be held on the same day)
Takemori Motoi (竹森 基)
Previous positionGeneral Manager of the Corporate Planning Department
New positionDirector and General Manager, Corporate Planning Department
Uno Fumiyasu (宇野 史泰)
Previous positionGeneral Manager, Finance and Accounting Department
New positionDirector and General Manager, Finance and Accounting Department
Date of birthTakemori Motoi (竹森 基): born 10 August 1965; Uno Fumiyasu (宇野 史泰): Not disclosed
Year joined the companyTakemori Motoi (竹森 基): 1994; Uno Fumiyasu (宇野 史泰): Not disclosed
Because the names and counts do not correspond, they are shown as reported without linking the counts to individual names.

Departing officer

1 item
Date of departure28 August 2026 (appears to be after the annual general meeting of shareholders, but this is not explicitly stated)
Shibata Futoshi (柴田 太)Next role stated
Former PositionDirector and General Manager of the Legal Affairs Department
New positionGeneral Manager, Legal Affairs Department

“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.

Whether the incumbent will remain in office (whether they will retain their position)

Will not remain on the Board of Directors

Shareholders’ meeting approvalRequired. A proposal for the election of director candidates is scheduled to be submitted to the 44th Annual General Meeting of Shareholders, which is scheduled to be held on 28 August 2026.
Who is moving to which position
ItemDetails
Resolution date3 August 2026
Scheduled Appointment Date28 August 2026 (after being elected as directors at the annual general meeting of shareholders, their positions are scheduled to be formally determined at a Board of Directors meeting to be held on the same day)
Date of departure28 August 2026 (appears to be after the annual general meeting of shareholders, but this is not explicitly stated)
Name of appointeeTakemori Motoi (竹森 基), Uno Fumiyasu (宇野 史泰)
Appointee's new positionDirector and General Manager, Corporate Planning Department, Director and General Manager, Finance and Accounting Department
Appointee's previous positionGeneral Manager of the Corporate Planning Department, General Manager, Finance and Accounting Department
Appointee's date of birthTakemori Motoi (竹森 基): born 10 August 1965; Uno Fumiyasu (宇野 史泰): Not disclosed
Year the appointee joined the CompanyTakemori Motoi (竹森 基): 1994; Uno Fumiyasu (宇野 史泰): Not disclosed
Name of departing officerShibata Futoshi (柴田 太)
Former position of departing officerDirector and General Manager of the Legal Affairs Department
New position of departing officerGeneral Manager, Legal Affairs Department
Whether the incumbent will remain in officeWill not remain on the Board of Directors
Subject to Approval by the General Meeting of ShareholdersRequired. A proposal for the election of director candidates is scheduled to be submitted to the 44th Annual General Meeting of Shareholders, which is scheduled to be held on 28 August 2026.
Items this document does not state (8)
Number of shares held by the appointeeReason for departureReason for changeReasons for appointmentNumber of directors after the changeFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company explains that it has determined the candidates for director, but does not provide specific reasons for the personnel changes.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Changes in Officers | COSMOS Pharmaceutical Corporation (3349) timely disclosure | Komori